We performed a series of mechanistic investigations assessing expression and distribution of VDR in AD brains and sought to determine the role of VDR/p53 complex formation in the pathogenesis of AD with the use of a chemical inhibitor of p53 in AD mice. The gene discussed is VDR; the disease is Alzheimer disease.